Nigel Bark

1.6k total citations
30 papers, 1.2k citations indexed

About

Nigel Bark is a scholar working on Psychiatry and Mental health, Clinical Psychology and Philosophy. According to data from OpenAlex, Nigel Bark has authored 30 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Psychiatry and Mental health, 7 papers in Clinical Psychology and 5 papers in Philosophy. Recurrent topics in Nigel Bark's work include Schizophrenia research and treatment (18 papers), Bipolar Disorder and Treatment (7 papers) and Electroconvulsive Therapy Studies (6 papers). Nigel Bark is often cited by papers focused on Schizophrenia research and treatment (18 papers), Bipolar Disorder and Treatment (7 papers) and Electroconvulsive Therapy Studies (6 papers). Nigel Bark collaborates with scholars based in United States, Armenia and United Kingdom. Nigel Bark's co-authors include Leslie Citrome, Thomas B. Cooper, Pál Czobor, Herbert M. Lachman, Rael D. Strous, Menahem Krakowski, Jean‐Pierre Lindenmayer, Jan Volavka, Sandra Grochowski and Jean-Pierre Lindenmayer and has published in prestigious journals such as Biological Psychiatry, The British Journal of Psychiatry and Psychopharmacology.

In The Last Decade

Nigel Bark

29 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nigel Bark United States 13 666 275 206 154 153 30 1.2k
Ronald Brenner United States 25 933 1.4× 175 0.6× 282 1.4× 199 1.3× 157 1.0× 60 1.6k
Jack Hirschowitz United States 22 812 1.2× 144 0.5× 272 1.3× 136 0.9× 209 1.4× 63 1.4k
Grant N. Ko United States 17 504 0.8× 194 0.7× 390 1.9× 266 1.7× 158 1.0× 27 1.4k
R J Wyatt United States 14 777 1.2× 290 1.1× 258 1.3× 118 0.8× 232 1.5× 21 1.5k
Steve Mann Canada 17 684 1.0× 130 0.5× 177 0.9× 174 1.1× 99 0.6× 25 1.1k
J.-P. Olié France 16 423 0.6× 186 0.7× 151 0.7× 101 0.7× 214 1.4× 37 1.1k
Michael D. Lesem United States 16 943 1.4× 704 2.6× 137 0.7× 111 0.7× 86 0.6× 24 2.0k
Jun Ishigooka Japan 24 757 1.1× 167 0.6× 196 1.0× 241 1.6× 223 1.5× 123 1.6k
Spyridon Siafis Germany 22 985 1.5× 258 0.9× 119 0.6× 149 1.0× 149 1.0× 79 1.6k
Jeffery A. Lieberman United States 11 566 0.8× 126 0.5× 360 1.7× 175 1.1× 283 1.8× 14 1.1k

Countries citing papers authored by Nigel Bark

Since Specialization
Citations

This map shows the geographic impact of Nigel Bark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nigel Bark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nigel Bark more than expected).

Fields of papers citing papers by Nigel Bark

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nigel Bark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nigel Bark. The network helps show where Nigel Bark may publish in the future.

Co-authorship network of co-authors of Nigel Bark

This figure shows the co-authorship network connecting the top 25 collaborators of Nigel Bark. A scholar is included among the top collaborators of Nigel Bark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nigel Bark. Nigel Bark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bark, Nigel, et al.. (2016). Among the severely mentally ill, who responds to ziprasidone?. Clinical Schizophrenia & Related Psychoses. 12(aop). 1 indexed citations
3.
Bark, Nigel, et al.. (2011). Evaluation of the Routine Clinical Use of the Brief Psychiatric Rating Scale (BPRS) and the Abnormal Involuntary Movement Scale (AIMS). Journal of Psychiatric Practice. 17(4). 300–303. 8 indexed citations
4.
Bark, Nigel, et al.. (2008). Schizophrenia in history. Schizophrenia Research. 98. 25–25.
5.
Krakowski, Menahem, Pál Czobor, Leslie Citrome, Nigel Bark, & Thomas B. Cooper. (2006). Atypical Antipsychotic Agents in the Treatment of Violent Patients With Schizophrenia and Schizoaffective Disorder. Archives of General Psychiatry. 63(6). 622–622. 234 indexed citations
6.
Smith, Robert C., et al.. (2005). Clozapine, risperidone, olanzapine, and conventional antipsychotic drug effects on glucose, lipids, and leptin in schizophrenic patients. The International Journal of Neuropsychopharmacology. 8(2). 183–194. 53 indexed citations
7.
Citrome, Leslie, Richard C. Josiassen, Nigel Bark, Daniel E. Salazar, & Suresh Mallikaarjun. (2004). Pharmacokinetics of Aripiprazole and Concomitant Lithium and Valproate. The Journal of Clinical Pharmacology. 45(1). 89–93. 71 indexed citations
8.
Bark, Nigel. (2002). Did schizophrenia change the course of English history? The mental illness of Henry VI. Medical Hypotheses. 59(4). 416–421. 3 indexed citations
9.
Bark, Nigel, et al.. (2002). The impact of cognitive remediation on psychiatric symptoms of schizophrenia. Schizophrenia Research. 63(3). 229–235. 66 indexed citations
10.
Javitt, Daniel C., Gail Silipo, Angel Cienfuegos, et al.. (2001). Adjunctive high-dose glycine in the treatment of schizophrenia. The International Journal of Neuropsychopharmacology. 4(4). 385–91. 155 indexed citations
11.
Volavka, Jan, Thomas B. Cooper, Pál Czobor, et al.. (2000). High-Dose Treatment With Haloperidol: The Effect of Dose Reduction. Journal of Clinical Psychopharmacology. 20(2). 252–256. 25 indexed citations
12.
Bark, Nigel. (1998). Deaths of Psychiatric Patients During Heat Waves. Psychiatric Services. 49(8). 1088–1090. 77 indexed citations
14.
Strous, Rael D., Nigel Bark, Margaret G. Woerner, & Herbert M. Lachman. (1997). Lack of association of functional cathechol-O-methyltransferase gene polymorphism in schizophrenia. Biological Psychiatry. 41(4). 493–495. 57 indexed citations
15.
Lindenmayer, Jean‐Pierre, et al.. (1997). Heterogeneity of serotonergic response in treatment-refractory schizophrenia patients. Biological Psychiatry. 42(1). 6–12. 9 indexed citations
16.
Lindenmayer, Jean-Pierre, et al.. (1997). Cognitive Deficits and Psychopathology in Elderly Schizophrenic Patients. American Journal of Geriatric Psychiatry. 5(1). 31–42. 7 indexed citations
17.
Lindenmayer, Jean‐Pierre, et al.. (1995). Psychopathology of Schizophrenia: Initial Validation of a 5-Factor Model. Psychopathology. 28(1). 22–31. 123 indexed citations
18.
Lindenmayer, Jean‐Pierre, et al.. (1992). BEHAVIORAL RESPONSE TO MCPP CHALLENGE IN CHRONIC SCHIZOPHRENICS. Clinical Neuropharmacology. 15. 23B–23B. 1 indexed citations
19.
Bark, Nigel. (1982). The Prevention and Treatment of Heatstroke in Psychiatric Patients. Psychiatric Services. 33(6). 474–476. 6 indexed citations
20.
Bark, Nigel. (1979). Fertility and Offspring of Alcoholic Women: An Unsuccessful Search for the Fetal Alcohol Syndrome. British Journal of Addiction to Alcohol & Other Drugs. 74(1). 43–49. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026